Evidence map›Paper›PMID 39084496›Full record

ArticleActa biomaterialia2024

A three-dimensional valve-on-chip microphysiological system implicates cell cycle progression, cholesterol metabolism and protein homeostasis in early calcific aortic valve disease progression.

Ishita Tandon, Alan E Woessner, Laίs A Ferreira, Christine Shamblin, Gustavo Vaca-Diez, Amanda Walls, Patrick Kuczwara, Alexis Applequist, Denise F Nascimento, Swastika Tandon and 9 more

Abstract read
In one paragraph

Article in Acta biomaterialia, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. CD8Nature reviews. Cardiology · 2026
    Review
  2. Bridging the Gap Between Static Histology and Dynamic Organ-on-a-Chip Models.Pathophysiology : the official journal of the International Society for Pathophysiology · 2026
    Review
  3. Review
  4. Review
  5. Design strategy primer for organ-on-chips.Biomaterials translational · 2025
    Article
  6. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors.

Ishita TandonDepartment of Biomedical Engineering, University of Arkansas, Fayetteville, AR, USA.
Alan E WoessnerArkansas Integrative Metabolic Research Center, University of Arkansas, Fayetteville, AR, USA.
Laίs A FerreiraDepartment of Biomedical Engineering, University of Arkansas, Fayetteville, AR, USA.
Christine ShamblinScripps Research Institute, La Jolla, CA, USA.
Gustavo Vaca-DiezDepartment of Biomedical Engineering, University of Arkansas, Fayetteville, AR, USA.
Amanda WallsDepartment of Biomedical Engineering, University of Arkansas, Fayetteville, AR, USA.
Patrick KuczwaraDepartment of Biological and Agricultural Engineering, Materials Science & Engineering, University of Arkansas, Fayetteville, AR, USA.
Alexis ApplequistDepartment of Biomedical Engineering, University of Arkansas, Fayetteville, AR, USA.
Denise F NascimentoDepartment of Biomedical Engineering, University of Arkansas, Fayetteville, AR, USA.
Swastika TandonDepartment of Biomedical Engineering, University of Arkansas, Fayetteville, AR, USA.
Jin-Woo KimDepartment of Biological and Agricultural Engineering, Materials Science & Engineering, University of Arkansas, Fayetteville, AR, USA.
Manuel RauschDepartments of Aerospace Engineering and Engineering Mechanics and Biomedical Engineering, Institute for Computational Engineering and Science, University of Texas at Austin, Austin, TX, USA.
Tomasz TimekMeijer Heart and Vascular Institute at Spectrum Health, Grand Rapids, MI, USA.
Muralidhar PadalaDivision of Cardiothoracic Surgery, Joseph P. Whitehead Department of Surgery, Emory University, Atlanta, GA, USA.
Michael T KinterAging & Metabolism Research Program, Oklahoma Medical Research Foundation, Oklahoma City, OK, USA.
Dennis ProvinceDepartment of Biochemistry and Molecular Biology, University of Arkansas for Medical Sciences, Little Rock, AR, USA.
Stephanie D ByrumDepartment of Biochemistry and Molecular Biology, University of Arkansas for Medical Sciences, Little Rock, AR, USA.
Kyle P QuinnDepartment of Biomedical Engineering, University of Arkansas, Fayetteville, AR, USA; Arkansas Integrative Metabolic Research Center, University of Arkansas, Fayetteville, AR, USA.
Kartik BalachandranDepartment of Biomedical Engineering, University of Arkansas, Fayetteville, AR, USA. Electronic address: kbalacha@uark.edu.

Funding

Translational Regulation in Normal Erythropoiesis and Diamond Blackfan AnemiaP20GM121293 · NIGMS · ARKANSAS CHILDREN'S HOSPITAL RES INST · PI Alan Tackett · 2017 to 2026
$27.6M
Unraveling Gene-Environment Interactions Shaping Metabolism: A Multi-Omics Analysis in DrosophilaP20GM139768 · NIGMS · UNIVERSITY OF ARKANSAS AT FAYETTEVILLE · PI Joanna Fiddler · 2021 to 2026
$17.0M
Supplement for Google cloud build-outR24GM137786 · NIGMS · UNIV OF ARKANSAS FOR MED SCIS · PI Alan Tackett · 2020 to 2026
$15.4M
Using an Electrospun Surrogate Model to Investigate Mechanisms of Tricuspid Valve MaladaptationR01HL165251 · NHLBI · UNIVERSITY OF TEXAS AT AUSTIN · PI MANUEL Karl RAUSCH · 2022 to 2026
$4.3M
In vivo label-free characterization of aged skin to predict delayed wound healingR01AG056560 · NIA · UNIVERSITY OF ARKANSAS AT FAYETTEVILLE · PI QUINN, KYLE PATRICK · 2017 to 2021
$1.7M
Non-invasive automated wound analysis via deep learning neural networksR01EB031032 · NIBIB · UNIVERSITY OF ARKANSAS AT FAYETTEVILLE · PI QUINN, KYLE PATRICK · 2021 to 2024
$1.6M
Q Exactive HF-X Hybrid Quadrupole Orbitrap Mass SpectrometerS10OD026736 · OD · UNIV OF ARKANSAS FOR MED SCIS · PI MACKINTOSH, SAMUEL G. · 2019 to 2019
$764k
ACE2 SARS-CoV2-mediated valve disease in a microphysiological tissue-chip modelR15AI169564 · NIAID · UNIVERSITY OF ARKANSAS AT FAYETTEVILLE · PI BALACHANDRAN, KARTIK · 2022 to 2022
$437k
NHLBI NIH HHS R01 HL165251NIAID NIH HHS R15 AI169564NIA NIH HHS R01 AG056560NIBIB NIH HHS R01 EB031032NIGMS NIH HHS P20 GM121293NIGMS NIH HHS P20 GM139768NIGMS NIH HHS R24 GM137786NIH HHS S10 OD026736
6 · The paper itself

Abstract

backgroundCalcific aortic valve disease (CAVD) is one of the most common forms of valvulopathy, with a 50 % elevated risk of a fatal cardiovascular event, and greater than 15,000 annual deaths in North America alone. The treatment standard is valve replacement as early diagnostic, mitigation, and drug strategies remain underdeveloped. The development of early diagnostic and therapeutic strategies requires the fabrication of effective in vitro valve mimetic models to elucidate early CAVD mechanisms.

methodsIn this study, we developed a multilayered physiologically relevant 3D valve-on-chip (VOC) system that incorporated aortic valve mimetic extracellular matrix (ECM), porcine aortic valve interstitial cell (VIC) and endothelial cell (VEC) co-culture and dynamic mechanical stimuli. Collagen and glycosaminoglycan (GAG) based hydrogels were assembled in a bilayer to mimic healthy or diseased compositions of the native fibrosa and spongiosa. Multiphoton imaging and proteomic analysis of healthy and diseased VOCs were performed.

resultsCollagen-based bilayered hydrogel maintained the phenotype of the VICs. Proteins related to cellular processes like cell cycle progression, cholesterol biosynthesis, and protein homeostasis were found to be significantly altered and correlated with changes in cell metabolism in diseased VOCs. This study suggested that diseased VOCs may represent an early, adaptive disease initiation stage, which was corroborated by human aortic valve proteomic assessment.

conclusionsIn this study, we developed a collagen-based bilayered hydrogel to mimic healthy or diseased compositions of the native fibrosa and spongiosa layers. When the gels were assembled in a VOC with VECs and VICs, the diseased VOCs revealed key insights about the CAVD initiation process. STATEMENT OF SIGNIFICANCE: Calcific aortic valve disease (CAVD) elevates the risk of death due to cardiovascular pathophysiology by 50 %, however, prevention and mitigation strategies are lacking, clinically. Developing tools to assess early disease would significantly aid in the prevention of disease and in the development of therapeutics. Previously, studies have utilized collagen and glycosaminoglycan-based hydrogels for valve cell co-cultures, valve cell co-cultures in dynamic environments, and inorganic polymer-based multilayered hydrogels; however, these approaches have not been combined to make a physiologically relevant model for CAVD studies. We fabricated a bi-layered hydrogel that closely mimics the aortic valve and used it for valve cell co-culture in a dynamic platform to gain mechanistic insights into the CAVD initiation process using proteomic and multiphoton imaging assessment.

Indexed as

Aortic ValveAortic Valve StenosisCalcinosisCholesterolLab-On-A-Chip DevicesAnimalsCell CycleCoculture TechniquesDisease ProgressionEndothelial CellsExtracellular MatrixHomeostasisHumansHydrogelsMicrophysiological SystemsSwineCholesterolHydrogelsCollagen-GAG hydrogelMicrophysiological systemMultiphoton microscopyOrgan-on-chipProtein expressionValve cell metabolism

Identifiers

PMID39084496
PMCPMC11702842

What Socratic holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.